2-(5-{2-[4-(1,3-benzothiazol-2-yl)piperazine-1-sulfonyl]phenyl}-2H-tetrazol-2-yl)-N-cyclopentylacetamide
Chemical Structure Depiction of
2-(5-{2-[4-(1,3-benzothiazol-2-yl)piperazine-1-sulfonyl]phenyl}-2H-tetrazol-2-yl)-N-cyclopentylacetamide
2-(5-{2-[4-(1,3-benzothiazol-2-yl)piperazine-1-sulfonyl]phenyl}-2H-tetrazol-2-yl)-N-cyclopentylacetamide
Compound characteristics
| Compound ID: | D216-0623 |
| Compound Name: | 2-(5-{2-[4-(1,3-benzothiazol-2-yl)piperazine-1-sulfonyl]phenyl}-2H-tetrazol-2-yl)-N-cyclopentylacetamide |
| Molecular Weight: | 552.68 |
| Molecular Formula: | C25 H28 N8 O3 S2 |
| Smiles: | C1CCC(C1)NC(Cn1nc(c2ccccc2S(N2CCN(CC2)c2nc3ccccc3s2)(=O)=O)nn1)=O |
| Stereo: | ACHIRAL |
| logP: | 3.7475 |
| logD: | 3.7475 |
| logSw: | -3.9743 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 107.411 |
| InChI Key: | IWBXTQPNJZABKP-UHFFFAOYSA-N |